The neonatal treatment of rats with monosodium glutamate induces morphological changes in the subfornical organ

Journal of Veterinary Medicine Series C: Anatomia Histologia Embryologia

Volumn 33, Issue 5, 2004, Pages 273-277

  Pesini, P ^a   Rois, J L ^a   Menendez L ^a   Vidal, S ^a  

^a University of Santiago de Compastela   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; GLUTAMATE SODIUM; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE;

ARTICLE; CELL COUNT; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; MALE; MORPHOLOGY; NEWBORN; NITRERGIC NERVE; NONHUMAN; ORGAN SIZE; RAT; SUBFORNICAL ORGAN;

AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; BLOOD PRESSURE; DRINKING; FEMALE; MALE; ORGAN SIZE; RATS; SODIUM GLUTAMATE; SUBFORNICAL ORGAN;

ANIMALIA;

EID: 4644327548     PISSN: 03402096     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1439-0264.2004.00547.x     Document Type: Article

References (44)

1. Alm, P., G. Skagerberg, A. Nylen, B. Larsson, and K. E. Andersson, 1997: Nitric oxide synthase and vasopressin in rat circumventricular organs. An immunohistochemical study. Exp. Brain Res. 117, 59-66.
2. Aoki, C., J. Rhee, M. Lubin, and T. M. Dawson, 1997: NMDA-R1 subunit of the cerebral cortex co-localizes with neuronal nitric oxide synthase at pre- and postsynaptic sites and in spines. Brain Res. 750, 25-40.
3. Aoki, C., D. S. Bredt, S. Fenstemaker, and M. Lubin, 1998: The subcellular distribution of nitric oxide synthase relative to the NR1 subunit of NMDA receptors in the cerebral cortex. Prog. Brain Res. 118, 83-97.
4. Bakke, J. E., N. Lawrence, J. Bennett, S. Robinson, and C. Y. Bowers, 1978: Late endocrine effects of administering monosodium glutamate to neonatal rats. Neuroendocrinology 26, 220-228.
5. Bhat, G. K., V. B. Mahesh, C. A. Lamar, L. Ping, K. Aguan, and D. W. Brann, 1995: Histochemical localization of nitric oxide neurons in the hypothalamus: association with gonadotropin-releasing hormone neurons and co-localization with N-methyl-D-aspartate receptors. Neuroendocrinology 62, 187-197.
6. van den Buuse, E. M., D. H. G. Versteeg, and W. de Jong, 1985: Effects of neonatal treatment with monosodium-glutamate in spontaneously hypertensive rats. Brain Res. 351, 135-138.
7. Clough, R. W., P. F. Aravich, and C. D. Sladek, 1986: Monosodium glutamate neurotoxicity: a sex-specific impairment of blood pressure but not vasopressin in developing rats. Brain Res. Bull. 17, 51-58.
8. Dawson, T. M., D. S. Bredt, M. Fotuhi, P. M. Hwang, and S. H. Snyder, 1991: Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues. Proc. Natl. Acad. Sci. U.S.A 88, 7797-7801.
9. Gracy, K. N., and V. M. Pickel, 1997: Ultrastructural localization and comparative distribution of nitric oxide synthase and N-methyl-D-aspartate receptors in the shell of the rat nucleus accumbens. Brain Res. 747, 259-272.
10. Hamaoka, K., and T. Sawada, 1987: Hypoplastic heart induced by neonatal hypothalamic lesions in mice. J. Mol. Cell Cardiol. 19, 741-749.
11. Hambley, J. W., G. A. Johnston, and L. J. Rogers, 1987: Blood pressure development in SHR and WKY rats: effects of neonatal monosodium glutamate treatment and evidence for transient hypertension in WKY rats. Neurosci. Lett. 83, 190-194.
12. Holzwarth-McBride, M. A., E. M. Hurst, and K. M. Knigge, 1976: Monosodium glutamate induced lesions of the arcuate nucleus. I. Endocrine deficiency and ultrastructure of the median eminence. Anat. Rec. 186, 185-205.
13. Hope, B. T., G. J. Michael, K. M. Knigge, and S. R. Vincent, 1991: Neuronal NADPH diaphorase is a nitric oxide synthase. Proc. Natl. Acad. Sci. U.S.A 88, 2811-2814.
14. Izumi, Y., A. M. Benz, D. B. Clifford, and C. F. Zorumski, 1992: Nitric oxide inhibitors attenuate N-methyl-D-aspartate excitotoxicity in rat hippocampal slices. Neurosci. Lett. 135, 227-230.
15. Johnson, A. K., and A. D. Loewy, 1990: Circumventricular organs and their role in visceral functions. In: Central Regulation of Autonomic Function (A. D. Loewy and K. M. Spyer eds). Oxford: Oxford University Press, pp. 247-267.
16. Johren, O., T. Inagami, and J. M. Saavedra, 1995: AT1A, AT1B, and AT2 angiotensin II receptor subtype gene expression in rat brain. Neuroreport 6, 2549-2552.
17. Kristova, V., M. Kriska, P. Babal, and D. Jezova, 1998: Early postnatal glutamate treatment results in altered vascular responsiveness to serotonin and noradrenaline in adult rats. Endocr. Regul. 32, 133-139.
18. Lage, R. C., M. J. Campagnole-Santos, M. A. Fontes, and R. A. Santos, 1999: Cardiovascular effects produced by nitric oxide-related drugs in the caudal ventrolateral medulla. Neuroreport 10, 731-735.
19. Lenkei, Z., P. Corvol, and C. Llorens-Cortes, 1995: The angiotensin receptor subtype AT1A predominates in rat forebrain areas involved in blood pressure, body fluid homeostasis and neuroendocrine control. Brain Res. Mol. Brain Res. 30, 53-60.
20. Lewis, S. J., E. J. Whalen, T. G. Beltz, and A. K. Johnson, 1999: Role of the anterior region of the third ventricle in the cardiovascular responses produced by systemic injection of a nitric oxide synthase inhibitor. Brain Res. 830, 191-194.
21. Lin, L. H. and W. T. Talman, 2000: N-methyl-D-aspartate receptors on neurons that synthesize nitric oxide in rat nucleus tractus solitarii. Neuroscience 100, 581-588.
22. Maiter, D., L. E. Underwood, J. B. Martin, and J. I. Koenig, 1991: Neonatal treatment with monosodium glutamate: effects of prolonged growth hormone (GH)-releasing hormone deficiency on pulsatile GH secretion and growth in female rats. Endocrinology 128, 1100-1106.
23. Meister, B., S. Ceccatelli, T. Hökfelt, N. E. Anden, M. Anden, and E. Theodorsson, 1989: Neurotransmitters, neuropeptides and binding sites in the rat mediobasal hypothalamus: effects of monosodium glutamate (MSG) lesions. Exp. Brain Res. 76, 343-368.
24. Moriguchi, S., N. Ohzuru, N. Koga, K. Honda, R. Saito, Y. Takano, and H. Kamiya, 1998: Central administration of a nitric oxide synthase inhibitor causes pressor responses via the sympathetic nervous system and the renin-angiotensin system in Wistar rats. Neurosci. Lett. 245, 109-112.
25. Mosqueda-Garcia, R., R. Eskay, N. Zamir, M. Palkovits, and G. Kunos, 1986: Opioid-mediated cardiovascular effects of clonidine in spontaneously hypertensive rats: elimination by neonatal treatment with monosodium glutamate. Endocrinology 118, 1814-1822.
26. Nemeroff, C. B., R. J. Konkol, G. Bissette, W. Youngblood, J. B. Martin, P. Brazeau, M. S. Rone, A. J. Prange Jr, G. R. Breese, and J. S. Kizer, 1977: Analysis of the disruption in hypothalamic-pituitary regulation in rats treated neonatally with monosodium L-glutamate (MSG): evidence for the involvement of tuberoinfundibular cholinergic and dopaminergic systems in neuroendocrine regulation. Endocrinology 101, 613-622.
27. Oldfield, B. J., and M. J. McKinley, 1995: Circumventricular organs. In: The Rat Nervous System (G. Paxinos ed.). London: Academic Press, pp. 391-403.
28. Olney, J. W., 1969: Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science 164, 719-721.
29. Olney, J. W., 1971: Glutamate-induced neuronal necrosis in the infant mouse hypothalamus. An electron microscopic study. J. Neuropathol. Exp. Neurol. 30, 75-90.
30. Oorschot, D. E., 1994: Are you using neuronal densities, synaptic densities or neurochemical densities as your definitive data? There is a better way to go. Prog. Neurobiol. 44, 233-247.
31. Phillips, M. I., L. Shen, E. M. Richards, and M. K. Raizada, 1993: Immunohistochemical mapping of angiotensin AT1 receptors in the brain. Regul. Pept. 44, 95-107.
32. Price, R. H., Jr, B. Mayer, and A. J. Beitz, 1993: Nitric oxide synthase neurons in rat brain express more NMDA receptor mRNA than non-NOS neurons. Neuroreport 4, 807-810.
33. Sakuma, I., H. Togashi, M. Yoshioka, H. Saito, M. Yanagida, M. Tamura, T. Kobayashi, H. Yasuda, S. S. Gross, and R. Levi, 1992: NG-methyl-L-arginine, an inhibitor of L-arginine-derived nitric oxide synthesis, stimulates renal sympathetic nerve activity in vivo. A role for nitric oxide in the central regulation of sympathetic tone? Circ. Res. 70, 607-611.
34. Sander, M., B. Chavoshan, and R. G. Victor, 1999: A large blood pressure-raising effect of nitric oxide synthase inhibition in humans. Hypertension 33, 937-942.
35. Schulz, J. B., R. T. Matthews, B. G. Jenkins, R. J. Ferrante, D. Siwek, D. R. Henshaw, P. B. Cipolloni, P. Mecocci, N. W. Kowall, and B. R. Rosen, 1995: Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo. J. Neurosci. 15, 8419-8429.
36. Scrogin, K. E., D. C. Hatton, Y. Chi, and F. C. Luft, 1998: Chronic nitric oxide inhibition with L-NAME: effects on autonomic control of the cardiovascular system. Am. J. Physiol. 274, R367-R374.
37. Tanaka, J., Y. Yamamuro, H. Saito, M. Matsuda, and M. Nomura, 1995: Differences in electrophysiological properties of angiotensinergic pathways from the subfornical organ to the median preoptic nucleus between normotensive Wistar-Kyoto and spontaneously hypertensive rats. Exp. Neurol. 134, 192-198.
38. Tokarev, D., and D. Jezova, 2000: Effect of nitric oxide inhibition on blood pressure and corticosterone responses in adult rats neonatally treated with glutamate. Physiol. Res. 49, 87-94.
39. Tokarev, D., V. Kristova, M. Kriska, and D. Jezova, 1997: Treatment of neonatal rats with monosodium glutamate attenuates the cardiovascular reactivity to phenylephrine and angiotensin II. Physiol. Res. 46, 165-171.
40. Vincent, S. R., 1995: Localization of nitric oxide neurons in the central nervous system. In: Nitric Oxide in the Nervous System (S. R. Vincent ed.). London: Academic Press, pp. 82-102.
41. Vincent, S. R. and H. Kimura, 1992: Histochemical mapping of nitric oxide synthase in the rat brain. Neuroscience 46, 755-784.
42. Weiss, S. W., D. S. Albers, M. J. Iadarola, T. M. Dawson, V. L. Dawson, and D. G. Standaert, 1998: NMDAR1 glutamate receptor subunit isoforms in neostriatal, neocortical, and hippocampal nitric oxide synthase neurons. J. Neurosci. 18, 1725-1734.
43. Zhang, K., W. G. Mayhan, and K. P. Patel, 1997: Nitric oxide within the paraventricular nucleus mediates changes in renal sympathetic nerve activity. Am. J. Physiol. 273, R864-R872.
44. Zhang, K., Y. F. Li, and K. P. Patel, 2001: Blunted nitric oxide-mediated inhibition of renal nerve discharge within PVN of rats with heart failure. Am. J. Physiol. Heart. Circ. Physiol. 281, H995-1004.